Lung function decline from adolescence to young adulthood in cystic fibrosis

Despite improving survival in cystic fibrosis (CF) patients, there is a mortality peak in early adulthood. Defining risk factors that predict significant worsening of lung disease in young adulthood may identify opportunities to improve outcomes in adults.

[1]  Charles A. Johnson,et al.  Factors influencing outcomes in cystic fibrosis: a center-based analysis. , 2003, Chest.

[2]  W. Morgan,et al.  Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis. , 2008, The Journal of pediatrics.

[3]  S. Butler,et al.  Patterns of medical practice in cystic fibrosis: Part II. Use of therapies , 1999, Pediatric pulmonology.

[4]  J. P. Singh,et al.  TREATMENT OUTCOME OF TUBERCULOSIS UNDER DIRECTLY OBSERVED TREATMENT SHORT COURSE (DOTS) IN PATIENTS PRESENTING AT CHEST TB HOSPITAL, AMRITSAR , 2005 .

[5]  E. Elkin,et al.  Year-to-year changes in lung function in individuals with cystic fibrosis. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[6]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[7]  J. Emerson,et al.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.

[8]  T. Liou,et al.  Predictive 5-year survivorship model of cystic fibrosis. , 2001, American journal of epidemiology.

[9]  Charles A. Johnson,et al.  Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. , 2007, The Journal of pediatrics.

[10]  S. Anker,et al.  Wasting as an independent predictor of mortality in patients with cystic fibrosis , 2001, Thorax.

[11]  Wiley Interscience,et al.  Predictors of mortality in adults with cystic fibrosis , 2007, Pediatric pulmonology.

[12]  M. Hodson,et al.  Changes in spirometry during consecutive admissions for infective pulmonary exacerbations in adolescent and adult cystic fibrosis. , 1992, Respiratory medicine.

[13]  N. Verma,et al.  Is there still a gender gap in cystic fibrosis? , 2005, Chest.

[14]  Charles A. Johnson,et al.  Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada , 1999, Pediatric pulmonology.

[15]  H. Parker.  Transition and transfer of patients who have cystic fibrosis to adult care. , 2007, Clinics in chest medicine.

[16]  P. McCray,et al.  Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis. , 2006, American journal of respiratory and critical care medicine.

[17]  W. Morgan,et al.  Clinical use of dornase alfa is associated with a slower rate of FEV1 decline in cystic fibrosis , 2011, Pediatric pulmonology.

[18]  S. Sawyer,et al.  The self-image of adolescents with cystic fibrosis. , 1995, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[19]  M. Rosenfeld,et al.  Gender gap in cystic fibrosis mortality. , 1997, American journal of epidemiology.

[20]  J. Garrett,et al.  Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study. , 1998, Pediatrics.

[21]  J. Patterson,et al.  Gender Differences in Young Adults' Perceptions of Living With Cystic Fibrosis During the Transition to Adulthood: A Qualitative Investigation , 2007 .

[22]  C. Mellis,et al.  Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis , 1992, Pediatric pulmonology.

[23]  A. Moran,et al.  Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality , 2009, Diabetes Care.